Possible Role of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Recovery of Post-COVID-19 Anosmia

References

• World Health Organization. Coronavirus disease (COVID-2019) situation reports; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Accessed April 9, 2020.
   Google Scholar
• Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): cases in U.S; 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html. Accessed April 9, 2020.
   Google Scholar
• Whittaker A, Anson M, Harky A. Neurological Manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020;142(1):14–22. doi:10.1111/ane.13266
   PubMed Web of Science ®Google Scholar
• Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet. 2020;395(10229):1014–1015. doi:10.1016/S0140-6736(20)30633-4
   PubMed Web of Science ®Google Scholar
• Lozada-Nur F, Chainani-Wu N, Fortuna G, Sroussi H. Dysgeusia in COVID-19: possible Mechanisms and Implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;130(3):344–346. doi:10.1016/j.oooo.2020.06.016
   Web of Science ®Google Scholar
• Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology. 2020;58(3):299–301. doi:10.4193/Rhin20.114
   PubMed Web of Science ®Google Scholar
• Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603–605. doi:10.1001/jama.2020.12603
   PubMed Web of Science ®Google Scholar
• Vaira LA, Salzano G, Fois AG, Piombino P, De Riu G. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol. 2020;10(9):1103–1104. doi:10.1002/alr.22593
   Web of Science ®Google Scholar
• Fodoulian L, Tuberosa J, Rossier D, et al. SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain. iScience. 2020;23(12):101839. doi:10.1016/j.isci.2020.101839
   Web of Science ®Google Scholar
• van Riel D, Verdijk R, Kuiken T. The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol. 2015;235(2):277–287. doi:10.1002/path.4461
   PubMed Web of Science ®Google Scholar
• Cazzolla AP, Lovero R, Lo Muzio L, et al. Taste and Smell Disorders in COVID-19 Patients: role of Interleukin-6. ACS Chem. Neurosci. 2020;11:2774–2781.
   Web of Science ®Google Scholar
• Dou Q, Chen H-N, Wang K, et al. Iver-mectin induces cytostatic autophagy by blocking the PAK1/Aktaxis in breast cancer. Cancer Res. 2016;76(15):4457–4469. doi:10.1158/0008-5472.CAN-15-2887
   PubMed Web of Science ®Google Scholar
• Zhang X, Song Y, Xiong H. Inhibitory effects of ivermectin on nitric oxide and prostaglandin E2 production in LPS-stimulated RAW 264.7 macrophages. Int Immunopharmacol. 2009;9(3):354–359. doi:10.1016/j.intimp.2008.12.016
   Web of Science ®Google Scholar
• Ci X, Li H, Yu Q. Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway. Fundam Clin Pharmacol. 2009;23(4):449–455. doi:10.1111/j.1472-8206.2009.00684.x
   Web of Science ®Google Scholar
• Ventre E, Rozières A, Lenief V. Topical ivermectin improves allergic skin inflammation. Allergy. 2017;72(8):1212–1221. doi:10.1111/all.13118
   PubMed Web of Science ®Google Scholar
• Abdelmaksoud AA, Ghweil AA, Hassan MH, et al. Olfactory Disturbances as Presenting Manifestation Among Egyptian Patients with COVID-19: possible Role of Zinc. Biol Trace Elem Res. 2021;3:1–8.
   Google Scholar
• González Canga A, Sahagún Prieto AM, Diez Liébana MJ, Fernández Martínez N, Sierra Vega M, García Vieitez JJ. The pharmacokinetics and interactions of ivermectin in humans--a mini-review. AAPS J. 2008;10(1):42–46. doi:10.1208/s12248-007-9000-9
   PubMed Web of Science ®Google Scholar
• Mastrangelo E, Pezzullo M, De Burghgraeve T, et al. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J Antimicrob Chemother. 2012;67(8):1884–1894. doi:10.1093/jac/dks147
   PubMed Web of Science ®Google Scholar
• Götz V, Magar L, Dornfeld D, et al. Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import. Sci Rep. 2016;6(1):23138. doi:10.1038/srep23138
   PubMed Web of Science ®Google Scholar
• Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 invitro. Antiviral Res. 2020;178:104787. doi:10.1016/j.antiviral.2020.104787
   PubMed Web of Science ®Google Scholar
• Ketkar H, Yang L, Wormser GP, Wang P. Lack of efficacy of ivermectin for prevention of a lethal Zika virus infection in a murine system. Diagn Microbiol Infect Dis. 2019;95(1):38–40. doi:10.1016/j.diagmicrobio.2019.03.012
   PubMed Web of Science ®Google Scholar
• Alshweiat A, Csóka I, Tömösi F, et al. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: preparation, characterization, and in vivo evaluation. Int J Pharm. 2020;579:119166. doi:10.1016/j.ijpharm.2020.119166
   PubMed Web of Science ®Google Scholar
• Alshweiat A, Ambrus R, Csoka I. Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery. Curr Med Chem. 2019;26(35):6459–6492. doi:10.2174/0929867326666190827151741
   PubMed Web of Science ®Google Scholar
• Aref ZF, Bazeed SEES, Hassan MH, et al. Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19. Int J Nanomedicine. 2021;16:4063–4072. doi:10.2147/IJN.S313093
   PubMed Web of Science ®Google Scholar
• Chong LY, Head K, Hopkins C, et al. Saline irrigation for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4(4):CD011995. doi:10.1002/14651858.CD011995.pub2
   Web of Science ®Google Scholar
• Yildiz E, Koca Yildiz S, Kuzu S, Günebakan Ç, Bucak A, Kahveci OK. Comparison of the Healing Effect of Nasal Saline Irrigation with Triamcinolone Acetonide Versus Nasal Saline Irrigation alone in COVID-19 Related Olfactory Dysfunction: a Randomized Controlled Study. Indian J Otolaryngol Head Neck Surg. 2021;1–6. doi:10.1007/s12070-021-02749-9
   Web of Science ®Google Scholar
• Prajapati DP, Shahrvini B, MacDonald BV, et al. Association of subjective olfactory dysfunction and 12-item odor identification testing in ambulatory COVID-19 patients. Int Forum Allergy Rhinol. 2020;10(11):1209–1217. doi:10.1002/alr.22688
   Web of Science ®Google Scholar
• Junior OV, Cardoso FAR, Giufrida WM, de Souza MF, Cardozo-Filho L. Production and computational fluid dynamics-based modeling of PMMA nanoparticles impregnated with ivermectin by a supercritical antisolvent process. J CO2 Util. 2020;35:47–58. doi:10.1016/j.jcou.2019.08.025
   Web of Science ®Google Scholar
• Xia D, Quan P, Piao H, et al. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci. 2010;40(4):325–334. doi:10.1016/j.ejps.2010.04.006
   PubMed Web of Science ®Google Scholar
• El-Mahdy MM, Hassan AS, El-Badry M, El-Gindy GE. Performance of curcumin in nanosized carriers niosomes and ethosomes as potential anti-inflammatory delivery system for topical application. Bull Pharm Sci Assiut. 2020;43(1):105–122. doi:10.21608/bfsa.2020.93599
   Google Scholar
• López-Medina E, López P, Hurtado IC, et al. Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: a Randomized Clinical Trial. JAMA. 2021;325(14):1426–1435. doi:10.1001/jama.2021.3071
   PubMed Web of Science ®Google Scholar
• Vallejos J, Zoni R, Bangher M, et al. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial. BMC Infect Dis. 2021;21(1):635. doi:10.1186/s12879-021-06348-5
   PubMed Web of Science ®Google Scholar
• Ahmed S, Karim MM, Ross AG, et al. A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int J Infect Dis. 2021;103:214–216. doi:10.1016/j.ijid.2020.11.191
   PubMed Web of Science ®Google Scholar
• Kow CS, Merchant HA, Mustafa ZU, Hasan SS. The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis. Pharmacol Rep. 2021;73(5):1473–1479. doi:10.1007/s43440-021-00245-z
   Web of Science ®Google Scholar
• Han AY, Mukdad L, Long JL, Lopez IA. Anosmia in COVID-19: mechanisms and Significance. Chem Senses. 2020;45(6):423–428. doi:10.1093/chemse/bjaa040
   Web of Science ®Google Scholar
• Stewart JN, Mounir S, Talbot PJ. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology. 1992;191(1):502–505. doi:10.1016/0042-6822(92)90220-J
   PubMed Web of Science ®Google Scholar
• Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory coronaviruses. J Virol. 2000;74(19):8913–8921. doi:10.1128/JVI.74.19.8913-8921.2000
   PubMed Web of Science ®Google Scholar
• Hung EC, Chim SS, Chan PK, et al. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem. 2003;49(12):2108–2109. doi:10.1373/clinchem.2003.025437
   PubMed Web of Science ®Google Scholar
• Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415–424. doi:10.1084/jem.20050828
   PubMed Web of Science ®Google Scholar
• Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637. doi:10.1002/path.1570
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. Provided by the U.S. National Library of Medicine. Available from: https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=ivermectin&cntry=&state=&city=&dist=. Accessed August 28, 2020.
   Google Scholar
• Maraie NK, Almajidi YQ. Application of nanoemulsion technology for preparation and evaluation of intranasal mucoadhesive nano-in-situ gel for ondansetron HCl. J Glob Pharm Technol. 2018;10(03):431–442.
   Google Scholar
• Saindane NS, Pagar KP, Vavia PR. Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization. AAPS PharmSciTech. 2013;14(1):189–199. doi:10.1208/s12249-012-9896-y
   PubMed Web of Science ®Google Scholar